Clinical Trial Update: Safety and Efficacy Study of Ceftaroline in Elderly Subjects With Community-Acquired Bacterial Pneumonia [Phase 4]

View source ↗

Summary

This report notes that a Phase 4 safety and efficacy trial of ceftaroline for elderly patients with community-acquired bacterial pneumonia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Bacterial Pneumonia

Drugs mentioned

• Teflaro (ceftaroline fosamil) (ceftaroline fosamil)

Snippet

Sponsor: Forest Laboratories | Conditions: Community-Acquired Bacterial Pneumonia (CABP) | Phase 4 | Status: WITHDRAWN